Resistant Starch Blood Glucose Randomized Trial: What the Evidence Says

Quick Answer

Resistant Starch Blood Glucose Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Improving glycemic control while minimizing hypoglycemia is a central objective because sustained near-normoglycemia is associated with fewer chronic complications and better quality of life. [Rogowicz-Frontczak Anita (2026); evidence level 2]
• In people without diabetes, RS-enriched foods and household approaches such as cooling and reheating cooked starches are often associated with smaller postprandial glucose and insulin responses, although the magnitude of the effect depends on the food matrix, amylose content, cooling duration, and number of heating-cooling cycles. [Rogowicz-Frontczak Anita (2026); evidence level 2]
• Their increasing prevalence has been strongly associated with the presence of multiple cardiometabolic risk factors-including elevated systolic blood pressure, high low-density lipoprotein cholesterol (LDL-c), elevated body mass index (BMI), and elevated fasting glucose-often exacerbated by unhealthy lifestyle behaviors such as physical inactivity and poor dietary habits. [Tavares Isabela Ribeiro Grangeira (2026); evidence level 4]
• According to the World Health Organization (WHO), these risk factors are interrelated and play a key role in the development of non-communicable diseases (NCDs), particularly cardiovascular diseases. [Tavares Isabela Ribeiro Grangeira (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For resistant starch blood glucose randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Rogowicz-Frontczak Anita (2026). Does Resistant Starch Formed by Cooling Pasta Decrease the Postprandial Glycemic Response in Type 1 Diabetes? A Randomized Single-Blind Crossover Study. DOI: 10.3390/nu18071152. PMCID: PMC13074698. PMID: 41978202. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13074698/
• Tavares Isabela Ribeiro Grangeira (2026). Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review. DOI: 10.1007/s13668-026-00766-0. PMCID: PMC13133204. PMID: 42060241. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13133204/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.